Want to see KR:002210 full AI Analyst Report?
Dongsung Pharmaceutical Co., Ltd. (002210) Financial Statements
Dongsung Pharmaceutical Co., Ltd. Financial Overview
Dongsung Pharmaceutical Co., Ltd.'s market cap is currently $112.91B. The company's EPS TTM is $-293.15; its P/E ratio is -4.08; and it has a dividend yield of 0.89%. Dongsung Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 87.17B | $ 88.45B | $ 88.59B | $ 93.33B | $ 84.41B |
| Gross Profit | $ 36.36B | $ 38.88B | $ 41.37B | $ 42.06B | $ 33.54B |
| Operating Income | $ -22.87B | $ -6.59B | $ 596.40M | $ -2.04B | $ -5.30B |
| EBITDA | $ -20.73B | $ -1.88B | $ 3.42B | $ 1.58B | $ -1.44B |
| Net Income | $ -25.74B | $ -7.25B | $ -2.07B | $ -2.12B | $ -4.31B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.86B | $ 3.15B | $ 6.44B | $ 4.09B | $ 5.14B |
| Total Assets | $ 168.44B | $ 151.91B | $ 114.97B | $ 107.70B | $ 104.58B |
| Total Debt | $ 64.13B | $ 52.09B | $ 43.27B | $ 37.04B | $ 29.31B |
| Net Debt | $ 60.27B | $ 48.95B | $ 36.84B | $ 32.94B | $ 26.17B |
| Total Liabilities | $ 145.07B | $ 96.73B | $ 75.17B | $ 64.89B | $ 58.14B |
| Stockholders' Equity | $ 23.37B | $ 55.18B | $ 39.80B | $ 42.81B | $ 46.44B |
| Cash Flow | |||||
| Free Cash Flow | $ -14.16B | $ -12.41B | $ -5.22B | $ -4.53B | $ -5.08B |
| Operating Cash Flow | $ -12.86B | $ -9.94B | $ -4.29B | $ -3.88B | $ -2.75B |
| Investing Cash Flow | $ 3.14B | $ -6.86B | $ -927.71M | $ 638.29M | $ -9.70B |
| Financing Cash Flow | $ 10.46B | $ 13.51B | $ 7.57B | $ 4.24B | $ 1.23B |
Currency in KRW